China Medical Technologies to Hold its Annual General Meeting on November 16, 2009

BEIJING, Oct. 28 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (NASDAQ:CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company will hold its annual general meeting of shareholders at the Company's office at 24 Yong Chang North Road, Beijing Economic-Technological Development Area, Beijing 100176, the People's Republic of China on November 16, 2009 at 9:00 a.m., local time.  Holders of record of ordinary shares of the Company at the close of business on October 2, 2009 are entitled to vote at the annual general meeting or any adjournment thereof in person or by proxy.  Holders of the Company's American Depositary Shares ("ADSs") who wish to exercise their voting rights for the underlying ordinary shares should follow the instructions that they receive from the depositary of the Company's ADS program, Citibank, N.A.

The notice of the annual general meeting, form of proxy card and the proxy statement that sets forth the proposal to be submitted for shareholders' approval at the meeting are available on the Company's Investor Relations website at http://ir.chinameditech.com/ .  The Company has filed its annual report, including its audited consolidated financial statements for the fiscal year ended March 31, 2009, on Form 20-F with the U.S. Securities and Exchange Commission (the "SEC").  The Company's annual report on Form 20-F can be accessed on the above-mentioned website of the Company, as well as on the SEC's website at http://www.sec.gov/ . Shareholders and ADS holders can request a hard copy of the Company's annual report, free of charge, by email to .

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders.  For more information, please visit http://www.chinameditech.com/ .

  For more information, please contact:

   Winnie Yam
   Tel:   [phone]
   Email: 

DATASOURCE: China Medical Technologies, Inc.



CONTACT: Winnie Yam, [phone], 



Web site: http://www.chinameditech.com/

http://ir.chinameditech.com/ 

Copyright